Recovery and survival from aging-associated diseases

被引:6
|
作者
Akushevich, Igor [1 ]
Kravchenko, Julia [2 ]
Ukraintseva, Svetlana [1 ]
Arbeev, Konstantin [1 ]
Yashin, Anatoliy I. [1 ]
机构
[1] Duke Univ, Ctr Populat Hlth & Aging, Durham, NC 27708 USA
[2] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27705 USA
关键词
Medicare; Chronic disease onset; Recovery; Long-term remission; Population-based analysis; US ELDERLY POPULATION; FREE LIFE EXPECTANCY; OLD-AGE DISABILITY; TERM-CARE SURVEY; FUNCTIONAL LIMITATION; MYOCARDIAL-INFARCTION; COMPETING RISKS; NATURAL-HISTORY; HEART-DISEASE; UNITED-STATES;
D O I
10.1016/j.exger.2013.05.056
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Considering disease incidence to be a main contributor to healthy lifespan of the US elderly population may lead to erroneous conclusions when recovery/long-term remission factors are underestimated. Using two Medicare-based population datasets, we investigated the properties of recovery from eleven age-related diseases. Methods: Cohorts of patients who stopped visiting doctors during a five-year follow-up since disease onset were analyzed non-parametrically and using the Cox proportional hazard model resulted in estimated recovery and survival rates and evaluated the health state of recovered individuals by comparing their survival with non-recovered patients and the general population. Results: Recovered individuals had lower death rates than non-recovered patients, therefore, patients who stopped visiting doctors are a healthier subcohort. However, they had higher death rates than in general population for all considered diseases, therefore the complete recovery does not occur. Conclusion: Properties of recovery/long-term remission among the US population of older adults with chronic diseases were uncovered and evaluated. The results allow for a better quantifiable contribution of age-related diseases to healthy life expectancy and improving forecasts of health and mortality. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:824 / 830
页数:7
相关论文
共 50 条
  • [1] Epigenetics of Aging and Aging-Associated Diseases
    Saul, Dominik
    Kosinsky, Robyn Laura
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 25
  • [2] mitochondria and aging-associated diseases
    Yanagi, Shigeru
    [J]. CANCER SCIENCE, 2021, 112 : 217 - 217
  • [3] Epigenetic Mechanisms of Aging and Aging-Associated Diseases
    la Torre, Annamaria
    Lo Vecchio, Filomena
    Greco, Antonio
    [J]. CELLS, 2023, 12 (08)
  • [4] mTOR Signaling in Aging and Aging-associated Diseases
    He Jie-Yu
    Liu Feng
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2014, 41 (03) : 257 - 265
  • [5] The emerging importance of lymphangiogenesis in aging and aging-associated diseases
    Ji, Rui-Cheng
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2024, 221
  • [6] A natural product solution to aging and aging-associated diseases
    Yang, Chuanbin
    Zhang, Wei
    Dong, Xiaoduo
    Fu, Chunjin
    Yuan, Jimin
    Xu, Menglong
    Liang, Zhen
    Qiu, Chen
    Xu, Chengchao
    [J]. PHARMACOLOGY & THERAPEUTICS, 2020, 216
  • [7] The involvement of stress granules in aging and aging-associated diseases
    Cao, Xiuling
    Jin, Xuejiao
    Liu, Beidong
    [J]. AGING CELL, 2020, 19 (04)
  • [8] RNA modifications in aging-associated cardiovascular diseases
    Yang, Xinyu
    Gokulnath, Priyanka
    Lehmann, H. Immo
    Hou, Zhitao
    Yang, Sun
    You, Liangzhen
    Zhang, Guoxia
    Xing, Yanwei
    Lei, Ji
    Li, Guoping
    Guo, Shuwen
    Shang, Hongcai
    [J]. AGING-US, 2022, 14 (19): : 8110 - 8136
  • [9] Antioxidant Supplementation in the Treatment of Aging-Associated Diseases
    Conti, Valeria
    Izzo, Viviana
    Corbi, Graziamaria
    Russomanno, Giusy
    Manzo, Valentina
    De Lise, Federica
    Di Donato, Alberto
    Filippelli, Amelia
    [J]. FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [10] Potential importance of B cells in aging and aging-associated neurodegenerative diseases
    Arya Biragyn
    Maria Aliseychik
    Evgeny Rogaev
    [J]. Seminars in Immunopathology, 2017, 39 : 283 - 294